Conducted as part of the MELCAYA project, the study demonstrates that anti PD-1 antibody immunotherapy is safe for children and adolescents. Furthermore, whilst it is effective for patients who have previously had their tumour removed, its effectiveness is diminished in more advanced cases, where metastasis has already spread to other organs.
2025
MMS-I Treatment Is Linked to Low Recurrence, Mortality in Head and Neck Melanoma
Mohs micrographic surgery with melanocytic immunostains (MMS-I) is emerging as an effective treatment option for invasive melanomas, particularly in anatomically constrained areas, due to a low risk of local recurrence and disease-specific mortality, according to study results published in Dermatologic Surgery.
Blood or Marrow Transplant Recipients Face High Risk for Skin Cancer
Survivors of blood or marrow transplant (BMT) face a significant risk of developing cutaneous malignant neoplasms, including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma, with a cumulative incidence of 27.4% over 30 years, according to the results of a cohort study.
John Lennon’s Son Julian, 61, Has Successful Skin Cancer Surgery After Second Melanoma Diagnosis.
Julian Lennon, the 61-year-old son of late Beatles icon John Lennon, was recently diagnosed with an aggressive form of skin cancer called melanoma for a second time. The first time it was found on his head four years ago. His most recent diagnosis was found on either his forearm or his shoulder.